Fundet i bogen – Side 412Gr. adj. polus many; L. part. adj. resistens resisting; N.L. part. adj. polyresistens resisting many (antibiotics). ... aureomycin (30), ciprofloxacin (10), erythromycin (15), gentamicin (10), kanamycin (5), netilimicin (10), ... Similarly, a significant rise in resistance over time was seen in studies reporting on community-acquired E. coli UTI. Springer Nature. Risk of bias among included studies was also investigated. Fundet i bogen – Side 670... chloramphenicol, Microbacterium but A. A-S), M. liquefaciens hypersensitivity gentamicin resistens (which is ... hassicum, heidelbergense, ethambutol, pyrazinamide, streptomycin, azithromycin, clarithromycin, ciprofloxacin, ... WGS analysis of a penicillin-resistant, Wu HM, Harcourt BH, Hatcher CP, et al. DNA gyrase; DNA topoisomerase; antibiotic resistance; efflux pump; experimental evolution; fluoroquinolone. 2012;109:1198–206. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. Isolates from meningococcal disease cases are submitted to CDC approximately every 6 months by health departments from all states, Washington, D.C., and New York City. However, the latter ranges were wide and the data were from a number of different Gram negative uropathogens and not specifically E. coli accounting for the higher rates. by Tong Yang, Zhenling Zeng, Lili Rao, Xiaojie Chen, Dandan He, Luchao Lv, Jing Wang, Li Zeng, Minsha Feng, Jian-Hua Liu. Population-based surveillance of, Tsang RSW, Ahmad T, Jamieson FB, Tyrrell GJ. A study by Gottesman et al. Article We investigated by whole genome sequencing the presence of crpP-genes and other mechanisms involved in quinolone resistance in MDR/XDR-Pseudomonas aeruginosa isolates (n = 55) with both ceftolozane-tazobactam susceptible or resistant profiles recovered from intensive care unit patients during the STEP . National Antimicrobial Resistance Strategy 2015–2019. 1. In a positive step in the fight against antibiotic resistance the number of countries tracking the issue has tripled since 2018, but they are finding that bacterial infections are becoming increasingly resistant to the medicines available to treat them, the . Tenover FC. Gram-negative bacteria are the main cause of community and hospital-acquired urinary tract infections (UTI). Shigella has shown increasing resistance to first- and second-line treatments, such as ciprofloxacin, azithromycin or trimethoprim-sulfamethoxazole, and antimicrobial-resistant Shigella has been . Google Scholar. These cases represent a substantial increase in penicillin-resistant and ciprofloxacin-resistant meningococci in the United States since 2013. McNamara LA, Blain A. Meningococcal disease. When a second case of infection with a β-lactamase–producing, ciprofloxacin-resistant NmY isolate was reported by the Maryland Department of Health in February 2020, a systematic analysis of N. meningitidis isolates in the United States was conducted to determine whether this resistance pattern was more widespread. In vitro . We would like to thank Associate Professor Elizabeth McInnes in reviewing the protocol and Ms Verena Schadewaldt for assisting with data retrieval. The factors responsible for high ciprofloxacin resistance are varied and are dependent on the genetic background of the isolates and the environment. Itasca, IL: American Academy of Pediatrics; 2018. 2013;85:94–105. Papers reporting on urinary E. coli ciprofloxacin susceptibility in which resistance rate could be calculated were also included. Aseptically unscrew and remove the cap from the ESwab. Ciprofloxacin resistance may also be transferred on DNA among bacteria of the same or different genus or species. Antimicrobial resistance in developing countries. For community-acquired UTI studies (Table 2), there was a significant difference in the pooled resistance within each subgroup examined (risk of bias, study duration, economy, region, age group and UTI symptoms). Accessibility Therefore the information provided in this systematic review and meta-analysis of 54 observational studies may not sufficiently address ciprofloxacin resistance globally but may provide satisfactory evidence to inform future interventions. Deliver to Microbiology laboratory. Maraki S, Mantadakis E, Michailidis L, Samonis G. Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005–2010. CDC is not responsible for the content
Ciprofloxacin is one of the most widely used antibiotics for treating Pseudomonas aeruginosa infections. There was no significant rise in resistance over time in developed countries. Furthermore, in some included studies, adjustments were not made for important confounding factors relevant to antimicrobial resistance such as antibiotic use and patient demographics including age and sex. CAS Fundet i bogen – Side 47AMP ampicillin ; CHL = chloramphenicol ; CIP = ciprofloxacin ; EAEC = enteroaggregative E. coli ; EPEC = enteropathogenic E. coli ; ETEC coli ; NAL nalidixic acid ; SXT = trimethoprim - sulfamethoxazole ; TET tetracycline . In all six WHO regions (Africa, Americas, Eastern Mediterranean, European, South-East Asia and Western Pacific) high rates of antimicrobial resistance have been observed in this pathogen [3]. Data sources include IBM Watson Micromedex (updated 11 Oct 2021), Cerner Multum™ (updated 1 Oct 2021), ASHP (updated 14 Oct 2021 . Table 1 provides further details on the description of the included studies. Most of the studies included in the review were found to have a high risk of bias as assessed using the NOS scale. Methods: Isogenic mutants expressing various levels of quinolone resistance, were tested in an in vitro bacterial adhesion assay using PMMA coverslips coated with increasing amounts of fibronectin. Multivariate analysis showed that higher age (OR 1.03; 95% CI 1.00-1.05) and use of two (OR 5.89; 95% CI 3.45-10.03) and three or more (OR 3.38; 95% CI 1.92-5.97) prescriptions of fluoroquinolones were associated with ciprofloxacin resistance, while no association between fluoroquinolone use more than 1 year before culture and . RR-2). The 33 isolates were from cases occurring in 12 states during 2013–2020 (Figure 1) (Figure 2). However, often studies do not apply the criterion of 48 h post admission used in our systematic review for identifying hospital acquired UTI [45, 46]. The first author, year of study, country of study, study setting, age and sex distribution, co-morbidities, sample size, study design, study aim, antimicrobial susceptibility testing method, ciprofloxacin resistance rate, risk factors for ciprofloxacin resistance (i.e. 6) showed asymmetry suggesting evidence of publication bias, with studies reporting high resistance rates being more likely to be published posing a limitation to this review. T Crucitti, S Belinga, MC Fonkoua, M Abanda, W Mbanzouen, E Sokeng, and A Nzouankeu. Ann Intern Med. During infection, P. aeruginosa produces a well-organized bacterial structure, called biofilm, activating the quorum-sensing (QS) signaling, a mechanism of gene regulation. Determination of the efflux pump-mediated resistance prevalence in Pseudomonas aeruginosa, using an efflux pump inhibitor. 2008;2:354–8. It belongs to a group of antibiotics called fluoroquinolones. Searches were conducted for words in the title or abstract or within the full text of the papers. Senegal J Infect Dev Ctries. A logistic regression model found that ciprofloxacin resistance was more common among S aureus isolated from the urinary and respiratory tracts than from other sites of isolation, and among isolates that were methicillin resistant. Resistance to the antibiotics used for meningococcal treatment and prophylaxis has been rare among N. meningitidis isolates in the United States (5). Harcourt BH, Anderson RD, Wu HM, et al. There are a number of notable strengths to our review. Fasugba, O., Gardner, A., Mitchell, B.G. 2013;13:85–90. Remaining black patients were non-Hispanic. All authors contributed to interpretation of the analysis. previous antibiotic use) and mortality data (if reported) were extracted. Our results pose a strong argument for the development of more stringent criteria limiting ciprofloxacin use. Arcobacter butzleri is a widely distributed emerging pathogen resistant to various classes of antimicrobial agents, namely fluoroquinolones.A. Acquisition of beta–lactamase by. Fundet i bogen – Side 33Endvidere fandtes ciprofloxacin - resistens praktisk taget ikke i Neonatalafsnittet , hvor ciprofloxacin ikke anvendes . I modsætning til resten af landet , er der fundet glycopeptid - resistente stammer på Rigshospitalet : 5 % af CONS ... Systematic reviews of studies investigating ciprofloxacin resistance in community- and hospital-acquired E. coli urinary tract infections (UTI) are absent. Ann Pharmacother. 2014;3:163–73. More countries report on antibiotic resistance but results are "worrying," says WHO. Von Elm E, Egger M. The scandal of poor epidemiological research: reporting guidelines are needed for observational epidemiology. Other likely causes of higher resistance in adults may be the greater likelihood of comorbidities with more frequent contact with healthcare settings [47]. The findings of this systematic review and meta-analysis highlight the higher ciprofloxacin resistance in hospital-acquired E.coli UTI when compared to community-acquired UTI. Article Stata Statistical Software: Release 13. Fundet i bogen – Side 297The patient was placed on ciprofloxacin 1. ... _____ ciprofloxacin B. cereus virulence factor OBJECTIVES • Corynebacterium resistens • Corynebacterium simulans • Corynebacterium striatum CHAPTER 15 297.e1 Bacillus and Similar Organisms. 2009;37:534–9. Patients were identified and followed using the healthcare databases of Emilia-Romagna Region, Italy. 2010;65:1514–20. Remove the swab. Prior to registration, the protocol was reviewed by a reviewer external to the study team. Mcquiston Haslund J, Rosborg Dinesen M, Sternhagen Nielsen AB, Llor C, Bjerrum L. Different recommendations for empiric first-choice antibiotic treatment of uncomplicated urinary tract infections in Europe. In recent years, antimicrobial resistance has been increasingly reported. In addition, other strategies such as adequate surveillance and monitoring, reinforcement of existing infection prevention and control measures as well as new technological advancement will help reduce the widespread problem of antimicrobial resistance [55–57] but these aspects are not within the scope of this paper. In vitro antimicrobial resistance of urinary Escherichia coli isolates among US outpatients from 2000 to 2010. Figure 4 shows the forest plot of studies reporting on ciprofloxacin resistance in hospital acquired E. coli UTI. Ciprofloxacin resistance in 1080 E. coli isolates was 10.2%. Wang Y, Zhao S, Han L, Guo X, Chen M, Ni Y, et al. Ann Clin Microbiol Antimicrob. Olson RP, Haith K. Antibiotic resistance in urinary tract infections in college students. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Ciprofloxacin is an antibiotic agent in the fluoroquinolone class used to treat bacterial infections such as urinary tract infections and pneumonia. PubMed Clipboard, Search History, and several other advanced features are temporarily unavailable. 2011;11:182–9. Google Scholar. Okeke IN, Lamikanra A, Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Antibiotic-resistant urinary tract infections are on the rise. 2005;46:457–60. 3) showed that Asia had the highest pooled resistance. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Bacterial non-coding RNAs (ncRNAs) play important regulatory roles in various physiological metabolic pathways. 8600 Rockville Pike J Microbiol Immunol Infect. Because close contacts of meningococcal disease patients have an elevated risk for disease (3), they are recommended to receive antibiotic prophylaxis with ciprofloxacin, rifampin, or ceftriaxone as soon as a suspected meningococcal disease case is identified (4). These findings show that penicillin-resistant and ciprofloxacin-resistant meningococci are now present in the United States; however, the complete geographic and temporal distribution of these resistant meningococci is unclear, because not all U.S. meningococcal disease cases have isolates available for WGS or antimicrobial susceptibility testing. KEYWORDS . 2004;93:487–91. It also has a documented safety profile, broad Gram negative organism coverage and high urinary excretion rate [4]. Google Scholar. 2013;35:872–7. References to non-CDC sites on the Internet are
Non-peer reviewed literature were also excluded. Ideally, these should be considered as hospital-acquired infections as some of these patients may have been discharged in the previous 48 h. For the purpose of this review and to overcome inherent variations in how individual studies have defined these patients, we classified all papers reporting on ED patients as community-acquired UTI studies. Glob J Health Sci. Fluoroquinolones are ranked as one of four of the highest priority critically important antimicrobials [7] as they have an important role in the treatment of more severe infections, such as septicaemia. 2002;113:45–54. Lucy A. McNamara, PhD1; Caelin Potts, PhD1; Amy E. Blain, MPH1; Adam C. Retchless, PhD1; Natashia Reese, MS2; Stephanie Swint, MS2; David Lonsway, MMSc2; Maria Karlsson, PhD2; Kristy Lunquest, ScM3; John J. Sweitzer, ScM3; Xin Wang, PhD1; Susan Hariri, PhD1; LeAnne M. Fox, MD1; Antimicrobial-Resistant Neisseria meningitidis Team (View author affiliations). Analysis of WGS data identified 11 serogroup Y isolates that contained a blaROB-1 β-lactamase gene and a T91I gyrA mutation associated with resistance to ciprofloxacin. This site needs JavaScript to work properly. Similar findings were observed for developing countries. Including all urinary E.coli isolates was considered but not done because this existing surveillance criterion (≥105 cfu/mL and 48 h cut off) is usually applied to defining infections not isolates. Compensatory evolution of Pseudomonas aeruginosa's slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis. The majority of the studies (80 %) followed a cross sectional design. Recent advances using high-throughput screens and experimental evolution combined with whole-genome sequencing and protein analysis are enhancing our understanding of the genetic and biochemical mechanisms involved in ciprofloxacin resistance. Ni Chulain M, Murray AM, Corbett-Feeney G, Cormican M. Antimicrobial resistance in E. Coli associated with urinary tract infection in the West of Ireland. Ongoing monitoring for antimicrobial resistance among meningococcal isolates and prophylaxis failures will be important to inform treatment and prophylaxis recommendations. During 2019–2020, 11 meningococcal isolates from U.S. patients had isolates containing a blaROB-1 β-lactamase gene associated with penicillin resistance and mutations associated with ciprofloxacin resistance. Of the identified 1134 papers, 53 were eligible for inclusion, providing 54 studies for analysis with one paper presenting both community and hospital studies. Hospital epidemiology and infection control in acute-care settings. This time limit is based on changes in the microbiology and epidemiology of antimicrobial resistant pathogens which occurred in the past decade with subsequent changes in treatment regimens and patient outcomes [12]. Data on E. coli in the WHO report are from various settings and sources (including blood and urine) hence cannot be directly compared with the results from our systematic review. and/or the original MMWR paper copy for printable versions of official text, figures, and tables. Nouri R, Ahangarzadeh Rezaee M, Hasani A, Aghazadeh M, Asgharzadeh M. Braz J Microbiol. United States Interagency Task Force on Antimicrobial Resistance. All 33 β-lactamase–containing isolates were in clonal complex 23 (CC23); 30, including all 11 with ciprofloxacin resistance mutations, were sequence type (ST)-3587; two were ST-15379; and one was ST-13034. Maron DF, Smith TJ, Nachman KE. CAS Australian Commission on Safety and Quality in Healthcare. Blaettler L, Mertz D, Frei R, Elzi L, Widmer A, Battegay M, et al. Microbiology. Given that children are less exposed to antimicrobials with limited ciprofloxacin use in the paediatric age group, this finding is expected [77–79]. Open Forum Infect Dis 2016;3:ofw152. Resistance to fluoroquinolones occurs primarily by either mutations in the DNA gyrases, decreased outer membrane permeability, or drug efflux. Antimicrobial resistance: global report on surveillance. Al-Orphaly M, Hadi HA, Eltayeb FK, Al-Hail H, Samuel BG, Sultan AA, Skariah S. mSphere. Hong E, Deghmane AE, Taha MK. 2009;49:869–75. The evolving threat of antimicrobial resistance: options for action. Although applying the internationally recognised CDC criteria may definitely be considered a strength as it ensures the quality and uniformity of included studies, this criterion limited the number of hospital-acquired UTI studies included in our systematic review. Blain AE, Mandal S, Wu H, et al. Despite this, resistance was still found to be higher in the hospital setting compared to the community setting similar to published studies. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. 2013;20:20–6. Penicillin use in meningococcal disease management: Active Bacterial Core Surveillance sites, 2009. This method incorporates an estimate of the between-study variation into both the study weights and the standard error of the estimate of the common effect. 2013;7:1027–30. Bethesda, MD 20894, Help coli evolved resistance to antibioti. Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997–2007. The Cochrane Collaboration. Figures 2 and 3 show the forest plots of studies reporting on ciprofloxacin resistance in community acquired E. coli UTI by region and economy, respectively. International Journal of STD & AIDS 2020 31: 6, 579-586 The dynamics of occurrence and the genetic basis of ciprofloxacin resistance were studied in a long-term evolution experiment (940 generations) in wild-type, reference strain (PAO1) and hypermutable (PAOΔmutS and PAOMY-Mgm) P. aeruginosa populations continuously exposed to sub-MICs (1/4) of ciprofloxacin. provided as a service to MMWR readers and do not constitute or imply
Collect the patient's sample using the swab. Google Scholar. Compared to the community setting, resistance to ciprofloxacin was significantly higher in the hospital setting (pooled resistance 0.38, 95 % CI 0.36-0.41 versus 0.27, 95 % CI 0.24-0.31 in community-acquired UTIs, P < 0.001). Fundet i bogen – Side 720Resistensutvikling er velkjent og sulfonamiddelen deltar ofte i R - faktoriell resistens . Oxytetracyklin . ... ( Negram ) og de såkalte quinolonene ( norfloxacin , ciprofloxacin , ofloxacin , pefloxacin m.fl. ) . Centers for Disease Control and Prevention. Am J Med. DOI: http://dx.doi.org/10.15585/mmwr.mm6924a2external icon. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Kashef N, Djavid GE, Shahbazi S. Antimicrobial susceptibility patterns of community-acquired uropathogens in Tehran. Dalhoff A. Penicillin-resistant and ciprofloxacin-resistant NmY isolates were detected in El Salvador during 2017–2019, but similar cases have not been reported elsewhere. et al. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. Nirmala Dhungana, California Department of Public Health; Ryan Gabrio-Brannon, California Department of Public Health; Jennifer Kyle, California Department of Public Health; Brittany Martin, California Department of Public Health; Meghan Barnes, Colorado Department of Public Health and Environment; Ashley Moore, Georgia Department of Public Health; Susan Hannagan, New Jersey Department of Health; Page Keating, New York City Department of Health and Mental Hygiene; Sandy Li, New York City Department of Health and Mental Hygiene; Justin Albertson, North Carolina Department of Health and Human Services; Wayne Fleming, Bureau of Epidemiology Pennsylvania Department of Health; Perrianne Lurie, Bureau of Epidemiology Pennsylvania Department of Health; Christina Russell, Bureau of Laboratories Pennsylvania Department of Health; Kara Reid, Philadelphia Department of Health; Kelsey Sanders, Texas Department of State Health Services; Chas DeBolt, Washington State Department of Health; Nicholas Graff, Washington State Department of Health; Esther Lam, Washington State Department of Health; Benjamin Hanisch, Children’s National Hospital Washington, DC; Gillian Taormina, Children’s National Hospital Washington, DC. MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services. Identification of one hundred and fifty‐eight strains was performed by PCR. Accessed 10 Nov 2014. Sire JM, Nabeth P, Perrier-Gros-Claude JD, Bahsoun I, Siby T, Macondo EA, et al. In countries like Spain, Taiwan and Turkey, the treatment choice for uncomplicated UTIs are fluoroquinolones [5, 58, 59]. Policy restrictions on ciprofloxacin use need to be developed and enforced especially in developing countries that are yet to have such policies put in place. Four-step Ciprofloxacin MEGA-plate, movie S3 from http://science.sciencemag.org/content/353/6304/1147Harvard Medical School / Technion -- Israel Institute of. 2015. http://www.health.gov.au/internet/main/publishing.nsf/Content/1803C433C71415CACA257C8400121B1F/$File/amr-strategy-2015-2019.pdf. Veterinary microbiology. This study systematically reviewed the literature and where appropriate, meta-analysed studies investigating ciprofloxacin resistance in community- and hospital-acquired E. coli UTIs. Owumi W, Banaei N, Shortliffe LD. ; CDC. In addition, papers not clearly specifying the setting (hospital-acquired or community-acquired); drug (ciprofloxacin) or sample (urine) were excluded. Accessed 10 Feb 2015. Ethics approval was not sought as this review synthesized data from published studies for which approval had already been obtained. In addition, this systematic review highlights the weaknesses in the quality of antimicrobial resistance data that are being collected in various regions. However, understanding of the basis of ciprofloxacin resistance is not yet complete. The most recent Infectious Diseases Society of America (IDSA) guidelines recommend that fluoroquinolones should be reserved for important uses due to their propensity for ecological unfavorable effects of antimicrobial therapy such as the selection of drug-resistant pathogens and colonisation or infection with multidrug-resistant organisms [9]. Article This review included only papers that used the Centers for Disease Control and Prevention (CDC) definition of microbiologically confirmed UTI (≥105 colony forming unit/ml) [14].